Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters

With randomised trial data confirming that continuous glucose monitoring (CGM) is associated with improvements in maternal glucose control and neonatal health outcomes, CGM is increasingly used in antenatal care. Across pregnancy, the ambition is to increase the CGM time in range (TIR), while reduci...

Descripción completa

Detalles Bibliográficos
Autor principal: Murphy, Helen R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560014/
https://www.ncbi.nlm.nih.gov/pubmed/31161344
http://dx.doi.org/10.1007/s00125-019-4904-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560014/
https://www.ncbi.nlm.nih.gov/pubmed/31161344
http://dx.doi.org/10.1007/s00125-019-4904-3

Ejemplares similares